Reflect Scientific Completes $550,000 Next-Generation Freezer Installation for Pharmaceutical Client
Reflect Scientific (RSCF) has successfully completed a significant $550,000 installation of multiple liquid nitrogen (LN2) freezers for a pharmaceutical client. The project, initially sold in Q3 2024 and completed in Q1 2025, represents an ongoing multi-year relationship with the unnamed client.
The company's next-generation freezers offer key advantages including ultra-low temperature capabilities for biopharmaceutical preservation, superior temperature stability versus conventional freezers, regulatory compliance, and enhanced energy efficiency. This installation strengthens RSCF's position in the specialized ultra-low temperature market, particularly within pharmaceutical and biotech sectors.
Reflect Scientific (RSCF) ha completato con successo un'importante installazione da 550.000 dollari di numerosi congelatori a azoto liquido (LN2) per un cliente farmaceutico. Il progetto, inizialmente venduto nel terzo trimestre del 2024 e completato nel primo trimestre del 2025, rappresenta una collaborazione pluriennale in corso con il cliente non nominato.
I congelatori di nuova generazione dell'azienda offrono vantaggi chiave, tra cui capacità di temperature ultra-basse per la conservazione biopharmaceutica, stabilità termica superiore rispetto ai congelatori tradizionali, conformità normativa e maggiore efficienza energetica. Questa installazione rafforza la posizione di RSCF nel mercato specializzato delle temperature ultra-basse, in particolare nei settori farmaceutico e biotecnologico.
Reflect Scientific (RSCF) ha completado con éxito una importante instalación de congeladores de nitrógeno líquido (LN2) por un valor de 550,000 dólares para un cliente farmacéutico. El proyecto, inicialmente vendido en el tercer trimestre de 2024 y finalizado en el primer trimestre de 2025, representa una relación multianual en curso con el cliente no identificado.
Los congeladores de última generación de la compañía ofrecen ventajas clave, incluyendo capacidades de temperatura ultra baja para la preservación biofarmacéutica, estabilidad térmica superior frente a congeladores convencionales, cumplimiento normativo y mayor eficiencia energética. Esta instalación fortalece la posición de RSCF en el mercado especializado de temperaturas ultra bajas, especialmente en los sectores farmacéutico y biotecnológico.
Reflect Scientific (RSCF)는 제약 고객을 위해 55만 달러 규모의 다수 액체 질소(LN2) 냉동고 설치를 성공적으로 완료했습니다. 이 프로젝트는 2024년 3분기에 판매되어 2025년 1분기에 완료되었으며, 이름이 공개되지 않은 고객과의 다년간 지속되는 관계를 나타냅니다.
회사의 차세대 냉동고는 생명공학 제약 보존을 위한 초저온 기능, 기존 냉동고 대비 우수한 온도 안정성, 규제 준수, 에너지 효율성 향상 등 주요 장점을 제공합니다. 이번 설치는 특히 제약 및 바이오테크 분야에서 RSCF의 초저온 전문 시장 내 입지를 강화합니다.
Reflect Scientific (RSCF) a réussi l'installation importante de plusieurs congélateurs à azote liquide (LN2) pour un client pharmaceutique, pour un montant de 550 000 dollars. Le projet, initialement vendu au troisième trimestre 2024 et achevé au premier trimestre 2025, s'inscrit dans une relation pluriannuelle continue avec ce client non nommé.
Les congélateurs de nouvelle génération de la société offrent des avantages clés, notamment des capacités ultra-basses pour la conservation biopharmaceutique, une stabilité thermique supérieure aux congélateurs conventionnels, la conformité réglementaire et une meilleure efficacité énergétique. Cette installation renforce la position de RSCF sur le marché spécialisé des températures ultra-basses, en particulier dans les secteurs pharmaceutique et biotechnologique.
Reflect Scientific (RSCF) hat erfolgreich eine bedeutende Installation von mehreren Flüssigstickstoff-(LN2)-Gefrierschränken im Wert von 550.000 US-Dollar für einen Pharma-Kunden abgeschlossen. Das Projekt, das im dritten Quartal 2024 verkauft und im ersten Quartal 2025 fertiggestellt wurde, stellt eine laufende mehrjährige Zusammenarbeit mit dem nicht genannten Kunden dar.
Die Gefrierschränke der nächsten Generation des Unternehmens bieten wesentliche Vorteile, darunter ultra-niedrige Temperaturfähigkeiten zur biopharmazeutischen Konservierung, überlegene Temperaturstabilität gegenüber herkömmlichen Gefrierschränken, regulatorische Konformität und verbesserte Energieeffizienz. Diese Installation stärkt die Position von RSCF im spezialisierten Ultratiefkühlmarkt, insbesondere in den Bereichen Pharma und Biotechnologie.
- Successfully completed a major $550,000 freezer installation project
- Demonstrates continuation of multi-year relationship with pharmaceutical client
- Technology offers competitive advantages in temperature stability and energy efficiency
- Shows growing market demand for company's patented LN2-based technologies
- None.
OREM, Utah, May 29, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leader in ultra-low temperature freezer technology, today announced the successful completion of a major installation project valued at
The installation was finalized during Q1 2025 and supports critical pharmaceutical storage and cold chain logistics operations. This deployment represents the continuation of a multi-year relationship with the client, whose name remains confidential per industry agreements.
"This successful installation demonstrates the growing market demand for our patented LN2-based technologies," said Kim Boyce, CEO of Reflect Scientific. "Our ultra-low temperature freezers are specifically designed to meet the exacting standards required for temperature-sensitive biopharmaceutical products, providing the stability and reliability that this industry demands."
The Company's next-generation freezers deliver several key competitive advantages:
- Ultra-low temperature capabilities essential for preserving biopharmaceutical integrity
- Superior temperature stability compared to conventional mechanical freezers
- Compliance with stringent regulatory requirements
- Enhanced energy efficiency, reducing operational costs
This latest deployment reinforces Reflect Scientific's position in the specialized ultra-low temperature market, particularly within the pharmaceutical and biotech sectors, where precise temperature control is critical for product efficacy and safety.
About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol "RSCF" and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading "Disclosure," including those identified in such filings as "forward-looking statements."

Contact Investor Relations 801-607-1039 info@reflectscientific.com